• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

东南亚疟疾、结核病和艾滋病毒的耐药性：生物学、项目及政策考量

Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.

作者信息

Panda Samiran, Swaminathan Soumya, Hyder Khurshid A, Christophel Eva-Maria, Pendse Razia N, Sreenivas Achuthan N, Laksono Setiwan J, Srivastava Rahul, Nair Gopinath B, Aditama Tjandra Y, Singhasivanon Pratap, Thapa Arun B, Sarkar Swarup K

机构信息

ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.

Indian Council for Medical Research, Government of India, New Delhi, India.

出版信息

BMJ. 2017 Sep 5;358:j3545. doi: 10.1136/bmj.j3545.

DOI:10.1136/bmj.j3545
PMID:28874362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5582343/
Abstract

Malaria, tuberculosis, and HIV present unique challenges in the control of antimicrobial resistance, and require targeted policies, say

摘要

疟疾、结核病和艾滋病毒在控制抗菌药物耐药性方面面临独特挑战，需要有针对性的政策，专家表示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94dc/5582343/aa691358b2e5/pans037180.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94dc/5582343/aa691358b2e5/pans037180.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94dc/5582343/aa691358b2e5/pans037180.f1.jpg

相似文献

1
Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.东南亚疟疾、结核病和艾滋病毒的耐药性：生物学、项目及政策考量
BMJ. 2017 Sep 5;358:j3545. doi: 10.1136/bmj.j3545.
2
Control of neglected tropical diseases: integrated chemotherapy and beyond.被忽视热带病的防治：综合化疗及其他措施
PLoS Med. 2006 Jan;3(5):e112. doi: 10.1371/journal.pmed.0030112.
3
[Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].[撒哈拉以南非洲地区HIV阳性成年人中的严重机会性感染]
Med Trop (Mars). 2006 Aug;66(4):343-5.
4
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.将针对被忽视热带病的快速影响一揽子计划纳入艾滋病、结核病和疟疾防治项目。
PLoS Med. 2006 Jan;3(5):e102. doi: 10.1371/journal.pmed.0030102.
5
"Big Three" Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS.三大传染病：结核病、疟疾和艾滋病。
Curr Top Med Chem. 2021;21(31):2779-2799. doi: 10.2174/1568026621666210916170417.
6
Ensuring access to life-saving medicines as countries shift from Global Fund support.随着各国不再依赖全球基金的支持，确保人们能够获得救命药物。
Bull World Health Organ. 2019 May 1;97(5):311-311A. doi: 10.2471/BLT.19.234468.
7
Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa.中非刚果人群中 HIV/AIDS、结核和疟疾合并感染的治疗中的药物遗传学考虑因素。
Int J Infect Dis. 2021 Mar;104:207-213. doi: 10.1016/j.ijid.2020.12.009. Epub 2020 Dec 9.
8
[Malaria and HIV co-infection].[疟疾与艾滋病毒合并感染]
Wiad Parazytol. 2006;52(1):9-11.
9
Tuberculosis and the human immunodeficiency virus: unholy marriage of the millennium.结核病与人类免疫缺陷病毒：千年的不祥结合。
East Afr Med J. 2008 Nov;85(11):521-2.
10
Eliminating malaria, tuberculosis & HIV/AIDS in South-East Asia: Why cross-border is so critical.在东南亚消除疟疾、结核病和艾滋病毒/艾滋病：跨境为何至关重要。
Indian J Med Res. 2022 Sep;156(3):368-371. doi: 10.4103/ijmr.ijmr_1271_22.

引用本文的文献

1
Generation of a new DiCre expressing parasite strain for functional characterization of Plasmodium falciparum genes in blood stages.生成一种新的 DiCre 表达寄生虫株，用于在血液阶段对疟原虫 falciparum 基因进行功能特征分析。
Sci Rep. 2024 Oct 15;14(1):24076. doi: 10.1038/s41598-024-75657-x.
2
Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1.表达伯氏疟原虫微线体相关抗原的病毒样颗粒比表达顶膜抗原 1 的病毒样颗粒具有更好的保护效果。
Parasites Hosts Dis. 2024 May;62(2):193-204. doi: 10.3347/PHD.24017. Epub 2024 May 27.
3

本文引用的文献

1
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.估算印度、菲律宾、俄罗斯和南非耐多药及广泛耐药结核病的未来负担：一项数学建模研究
Lancet Infect Dis. 2017 Jul;17(7):707-715. doi: 10.1016/S1473-3099(17)30247-5. Epub 2017 May 9.
2
Injecting drug use in India and the need for policy and program change.印度的注射吸毒现象以及政策和项目变革的必要性。
Int J Drug Policy. 2016 Nov;37:115-116. doi: 10.1016/j.drugpo.2016.08.009. Epub 2016 Oct 20.
3
Persistent HIV-1 replication maintains the tissue reservoir during therapy.
Community engagement approaches for malaria prevention, control and elimination: a scoping review.
社区参与方法在疟疾预防、控制和消除中的应用：综述
BMJ Open. 2024 Feb 15;14(2):e081982. doi: 10.1136/bmjopen-2023-081982.
4
Community engagement approaches for malaria prevention, control and elimination: a scoping review protocol.社区参与方法在疟疾预防、控制和消除中的应用：系统评价方案
BMJ Open. 2021 Oct 5;11(10):e049812. doi: 10.1136/bmjopen-2021-049812.
5
The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.绿色合成铜纳米颗粒对预防小鼠弓形虫感染的高效性
Acta Parasitol. 2021 Dec;66(4):1472-1479. doi: 10.1007/s11686-021-00421-4. Epub 2021 May 29.
6
Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime) in Cutaneous Leishmaniasis.绿色合成铜纳米颗粒单独或与葡甲胺锑酸盐（葡糖胺锑）联合用于皮肤利什曼病的治疗潜力
Nanomaterials (Basel). 2021 Mar 31;11(4):891. doi: 10.3390/nano11040891.
7
Dehydrobufotenin extracted from the Amazonian toad (Anura: Bufonidae) as a prototype molecule for the development of antiplasmodial drugs.从亚马逊蟾蜍（无尾目：蟾蜍科）中提取的脱氢蟾蜍色胺作为抗疟药物开发的原型分子。
J Venom Anim Toxins Incl Trop Dis. 2021 Jan 8;27:e20200073. doi: 10.1590/1678-9199-JVATITD-2020-0073. eCollection 2021.
8
Unintended Consequences and Hidden Obstacles in Medicine Access in Sub-Saharan Africa.撒哈拉以南非洲地区医疗服务获取中的意外后果与潜在障碍
Front Public Health. 2019 Nov 15;7:342. doi: 10.3389/fpubh.2019.00342. eCollection 2019.
9
The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.米替福新与环氧化合物（环氧-α-拉帕醌和环氧甲基劳森）联合治疗增强了感染嗜酸性粒细胞白血病（嗜酸性粒细胞）亚马逊的小鼠的杀利什曼原虫效果。
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:101-108. doi: 10.1016/j.ijpddr.2019.08.002. Epub 2019 Aug 12.
10
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial.泰国和缅甸基层医疗机构发热患者即时 C 反应蛋白检测对处方用抗生素的影响：一项开放标签、随机、对照试验。
Lancet Glob Health. 2019 Jan;7(1):e119-e131. doi: 10.1016/S2214-109X(18)30444-3.
在治疗期间，持续的HIV-1复制维持着组织储存库。
Nature. 2016 Feb 4;530(7588):51-56. doi: 10.1038/nature16933. Epub 2016 Jan 27.
4
Embedding operational research into national disease control programme: lessons from 10 years of experience in Indonesia.将运筹学融入国家疾病控制规划：印度尼西亚十年经验教训
Glob Health Action. 2014 Oct 23;7:25412. doi: 10.3402/gha.v7.25412. eCollection 2014.
5
The origins of antimalarial-drug resistance.抗疟药物耐药性的起源。
N Engl J Med. 2014 Jul 31;371(5):397-9. doi: 10.1056/NEJMp1403340.
6
Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India.印度浦那地区初治的1型人类免疫缺陷病毒感染儿童的耐药性患病率
AIDS Res Hum Retroviruses. 2014 Mar;30(3):294-8. doi: 10.1089/AID.2013.0222. Epub 2014 Feb 7.
7
Systematic review of HIV drug resistance in Southeast Asia.东南亚地区 HIV 耐药性的系统评价。
AIDS Rev. 2013 Jul-Sep;15(3):162-70.
8
Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.智取进化：抗击耐药结核、疟疾和艾滋病毒。
Cell. 2012 Mar 16;148(6):1271-83. doi: 10.1016/j.cell.2012.02.021.
9
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.结核分枝杆菌耐药性的分子基础和机制：经典药物和新药。
J Antimicrob Chemother. 2011 Jul;66(7):1417-30. doi: 10.1093/jac/dkr173. Epub 2011 May 9.
10
Update of the drug resistance mutations in HIV-1: December 2010.2010年12月HIV-1耐药性突变的更新情况。
Top HIV Med. 2010 Dec;18(5):156-63.